SCHEMBL19752004

SCHEMBL19752004

COCCc1cccc(N(Cc2ccccn2)C(=O)OC(C)(C)C)n1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.38
POLB P06746 1/20 0.37
HDAC1 Q13547 1/20 0.36
HDAC8 Q9BY41 1/20 0.36
HDAC6 Q9UBN7 1/20 0.36
KDM4E B2RXH2 4/20 0.35
F2 P00734 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
ALDH1A1 P00352 2/20 0.34
LMNA P02545 1/20 0.34
HPGD P15428 1/20 0.34
RAB9A P51151 1/20 0.34
HSD17B10 Q99714 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.34
HTT P42858 1/20 0.34
MLYCD O95822 1/20 0.34
PDE10A Q9Y233 1/20 0.34
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16407933 0.89 CYP1A2 (0.39) CYP1A2POLBHDAC1HDAC8HDAC6
SCHEMBL12733811 0.88 HRH1 (0.43) CYP1A2POLBHDAC1HDAC8HDAC6
SCHEMBL16407931 0.88 POLB (0.37) CYP1A2POLBHDAC1HDAC8HDAC6
SCHEMBL16407932 0.87 CYP1A2 (0.39) CYP1A2POLBHDAC1HDAC8HDAC6
SCHEMBL16407930 0.84 CYP1A2 (0.35) CYP1A2POLBHDAC1HDAC8HDAC6
SCHEMBL12733812 0.81 APP (0.45) CYP1A2POLBHDAC1HDAC8HDAC6
SCHEMBL12733850 0.80 PDE10A (0.40) CYP1A2KDM4EALDH1A1HSD17B10TSHR
SCHEMBL12733851 0.79 HSD17B10 (0.39) CYP1A2POLBKDM4EF2SMN1; SMN2
SCHEMBL12733789 0.79 HRH1 (0.45) CYP1A2KDM4EALDH1A1HSD17B10TSHR
SCHEMBL12733785 0.78 PDE10A (0.40) CYP1A2POLBKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2488513-B1 2,6-Diaminopyridine compounds for treating diseases associated with amyloid proteins or for treating ocular diseases AC IMMUNE SA (CH) 2017-12-27 EP disclosed